Bon C, Bouchier C, Choumet V, Faure G, Jiang M S, Lambezat M P, Radvanyi F, Saliou B
Laboratoire des Venins, Unité associée Pasteur/INSERM 285 Institut Pasteur, Paris, France.
Acta Physiol Pharmacol Latinoam. 1989;39(4):439-48.
Crotoxin, the major toxic component of the South American rattlesnake, Crotalus durissus terrificus, is a neurotoxic phospholipase A2 which exerts its pathophysiological action by blocking the neuromuscular transmission. Crotoxin acts primarily by altering the acetylcholine release from the nerves terminals through a mechanism which has not yet been elucidated. It also acts on postsynaptic membranes by stabilizing the acetylcholine receptor in an inactive conformation very similar to the desensitized state. Crotoxin is made of two dissimilar subunits: a basic and weakly toxic phospholipase A2 component-B, and an acidic and non toxic component-A which does not possess any enzymatic activity. Binding experiments showed that crotoxin subunits dissociate when crotoxin interacts with biological membranes: Component-B binds, whereas component-A appears free in solution. The phospholipase A2 subunit binds in a non saturable, non specific manner, on any kind of biological membranes, whereas in the presence of component-A it interacts only with a limited number of high affinity binding sites present on synaptic membranes but not on erythrocyte membranes. Although the target site (acceptor) of crotoxin has not yet been formally identified, binding experiments carried out with small unilamellar phospholipid vesicles of different compositions indicate that some negatively charged phospholipids like mono and diphosphoinositide phosphates might be an important component of crotoxin acceptor site. Crotoxin is in fact a mixture of several isoforms which have very similar but not identical polypeptide sequences. An individual Crotalus durissus terrificus snake is able to synthesize several crotoxin isoforms which may result of the expression of several isogenes and/or of post-translational events. When compared in quantitative manner, the crotoxin isoforms slightly but significantly differ in their enzymatic and pharmacological properties. Finally, immunochemical investigations carried out with polyclonal antibodies prepared against both crotoxin subunits, showed that non precipitating anti-component-B- antibodies (Fab) inhibit the phospholipase A2 activity of crotoxin and neutralize its lethal potency, suggesting that the catalytic and toxic sites of crotoxin are closely related.
响尾蛇毒素是南美响尾蛇(Crotalus durissus terrificus)的主要毒性成分,是一种神经毒性磷脂酶A2,它通过阻断神经肌肉传递发挥其病理生理作用。响尾蛇毒素主要通过一种尚未阐明的机制改变神经末梢乙酰胆碱的释放来发挥作用。它还通过将乙酰胆碱受体稳定在与脱敏状态非常相似的无活性构象来作用于突触后膜。响尾蛇毒素由两个不同的亚基组成:一个碱性且毒性较弱的磷脂酶A2成分B,以及一个酸性且无毒的成分A,该成分不具有任何酶活性。结合实验表明,当响尾蛇毒素与生物膜相互作用时,其亚基会解离:成分B结合,而成分A则游离于溶液中。磷脂酶A2亚基以非饱和、非特异性的方式结合在任何类型的生物膜上,而在成分A存在的情况下,它仅与突触膜上存在的有限数量的高亲和力结合位点相互作用,而不与红细胞膜相互作用。尽管响尾蛇毒素的靶位点(受体)尚未正式确定,但用不同组成的小单层磷脂囊泡进行的结合实验表明,一些带负电荷的磷脂,如单磷酸和二磷酸肌醇磷脂,可能是响尾蛇毒素受体位点的重要组成部分。事实上,响尾蛇毒素是几种同工型的混合物,它们具有非常相似但不完全相同的多肽序列。一条南美响尾蛇能够合成几种响尾蛇毒素同工型,这可能是几种同基因表达和/或翻译后事件的结果。当以定量方式进行比较时,响尾蛇毒素同工型在其酶学和药理学性质上略有但显著不同。最后,用针对两种响尾蛇毒素亚基制备的多克隆抗体进行的免疫化学研究表明,非沉淀性抗成分B抗体(Fab)抑制响尾蛇毒素的磷脂酶A2活性并中和其致死效力,这表明响尾蛇毒素的催化位点和毒性位点密切相关。